Improving Inpatient Screening for Hepatitis C
NCT04525690 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7634
Last updated 2021-08-17
Summary
This study will use a stepped-wedge cluster randomized clinical trial to evaluate a health system initiative to set defaults in the electronic health record admission order set to nudge inpatient hepatitis C (HCV) screening.
Conditions
- Hepatitis C
Interventions
- BEHAVIORAL
-
Nudge
Clinicians will receive a default order upon entering the the admission order set. They will have the opportunity to opt-out and not order screening. Clinicians will receive the nudge each time they enter the admission order set for a new, eligible patient.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Mitesh S Patel, MD · University of Pennsylvania
-
Shivan J Mehta, MD · University of Pennsylvania
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-09-21
- Primary Completion
- 2021-04-10
- Completion
- 2021-04-10
Countries
- United States
Study Locations
More Related Trials
-
Safety and Efficacy of Albumin Interferon Administered Every 4 Weeks in Genotype 2/3 Hepatitis C Patients
NCT00759200 ·Status: COMPLETED ·Phase: PHASE2
-
Electronic Record Assimilation and Subsequent Eradication of Hepatitis C
NCT04873609 ·Status: COMPLETED ·Phase: NA
-
Study Evaluating the Safety of HCV-796 in Subjects With Liver Disease and in Healthy Adults
NCT00314054 ·Status: COMPLETED ·Phase: PHASE1
-
Hepatitis C Screening Alerts
NCT05710120 ·Status: COMPLETED
-
Reasons for Non-treatment of Hepatitis C in HCV Mono-infected Patients Versus HCV-HIV Co-infected Patients in a University Setting
NCT00222859 ·Status: COMPLETED
-
Low-Dose Peginterferon and Ribavirin to Treat Chronic Hepatitis C in Patients Infected With HCV Genotype 2 or 3
NCT00056862 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Safety, Antiviral Effect, and Pharmacokinetics of Celgosivir in Combination With Peginterferon Alfa-2b and Ribavirin in Treatment-Naïve Patients With Chronic Hepatitis C
NCT00332176 ·Status: UNKNOWN ·Phase: PHASE2
-
Phase 1 Study To Evaluate Antiviral Activity Of Small Molecule Direct Antiviral Agent At Multiple Doses In Subjects With Chronically Infected Hepatitis C Virus.
NCT00671671 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy Study of New Therapeutic Schedules in Naive Hepatitis C Virus (HCV) Patients Infected With Genotype 3 (HCV-3)
NCT01121705 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Hepatic Responses in Patients Receiving Direct-acting Anti-HCV Drugs
NCT02532907 ·Status: COMPLETED
-
A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of the Combination of AL-335, Odalasvir, and Simeprevir
NCT02569710 ·Status: COMPLETED ·Phase: PHASE2
-
The Safety and Effectiveness of a Two-Drug Combination in the Treatment of Patients With Hepatitis C Plus Advanced HIV Infections
NCT00001035 ·Status: COMPLETED ·Phase: PHASE1
-
Racial Difference in HCV/Host Interactions
NCT00071916 ·Status: COMPLETED
-
A Caspase Inhibitor in Chronic Hepatitis C (HCV) Patients
NCT00088140 ·Status: COMPLETED ·Phase: PHASE2
-
Identification to Elimination in HCV-Infected Individuals
NCT03195205 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Hepatitis C Antiviral Resistance in African-Americans
NCT00038974 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study in Hepatitis C Patients With PHN121
NCT01052090 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
IdB 1016 Treatment for Hepatitis C Disease
NCT00055445 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Chronic Hepatitis C Virus Related Thrombocytopenia to Evaluate the Effects of E5501
NCT01355289 ·Status: COMPLETED ·Phase: PHASE2
-
An Observational Study of Peginterferon (e.g. Pegasys)-Based Direct Acting Antiviral Triple Therapy in Patients With Chronic Hepatitis C Genotype 1
NCT01508130 ·Status: COMPLETED
-
A Study of RO5428029 in Healthy Volunteers and Patients With Chronic Hepatitis C
NCT01371162 ·Status: COMPLETED ·Phase: PHASE1
-
Impact of Interferon-free Treatment for Hepatitis C Virus (HCV) on Blood Cells and Factors in Blood
NCT02718573 ·Status: COMPLETED
-
An Extension Study to Evaluate the Safety and Efficacy of Celgosivir and Peginterferon Alfa-2b, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype 1 Infection
NCT00292084 ·Status: COMPLETED ·Phase: PHASE2
-
Study of PPI-668, BI 207127 and Faldaprevir, With and Without Ribavirin, in the Treatment of Chronic Hepatitis C
NCT01859962 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety and Efficacy of Celgosivir and Peginterferon Alfa-2b, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype 1 Infection
NCT00217139 ·Status: COMPLETED ·Phase: PHASE2